Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Outcomes, Prognostic Factors and Salvage Treatment for Recurrent Chordoma After Pencil Beam Scanning Proton Therapy at the Paul Scherrer InstituteClinical Oncology.  32:537-544. 2020
2019 Overall survival is improved when DCIS accompanies invasive breast cancerScientific Reports.  9. 2019
2018 Early assessment of lung cancer immunotherapy response via circulating tumor DNAClinical Cancer Research.  24:1872-1880. 2018
2017 Acute radiation dermatitis in breast cancer patients: Challenges and solutionsBreast Cancer : Targets and Therapy.  9:313-323. 2017
2017 Predictors of nonadherence to NCCN guideline recommendations for the management of stage i anal canal cancer 2017
2016 Concurrent chemoradiotherapy versus radiotherapy alone for “biopsy-only” glioblastoma multiformeCancer.  122:2364-2370. 2016
2014 The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cellsScience Signaling2014
2013 Mature neurons: equipped for survival.Cell Death and Disease.  4. 2013
2011 miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosisGenes and Development.  25:125-130. 2011
2011 Activation of apoptosis by cytoplasmic microinjection of cytochrome c.Journal of Visualized Experiments2011
2004 Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominanceMolecular Cell.  16:425-438. 2004

Chapter

Year Title Altmetric
2016 Early Stage Breast Cancer 2016
2016 Locally Advanced Breast Cancer 2016
2014 Neuronal death mechanisms in development and disease.  167-188. 2014

Education And Training

  • Doctor of Medicine, University of North Carolina at Chapel Hill 2013
  • Doctor of Philosophy in Medical Cell Biology, University of North Carolina at Chapel Hill 2011
  • Bachelor of Arts in Chemistry, Duke University 2004
  • Full Name

  • Adam Kole